CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 93 filers reported holding CATALYST BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $844,000 | -36.8% | 194,933 | -26.5% | 0.00% | -100.0% |
Q1 2021 | $1,336,000 | +1249.5% | 265,157 | +1591.2% | 0.00% | – |
Q4 2020 | $99,000 | +86.8% | 15,679 | +29.5% | 0.00% | – |
Q3 2020 | $53,000 | -30.3% | 12,112 | -7.0% | 0.00% | – |
Q2 2020 | $76,000 | +81.0% | 13,024 | +35.7% | 0.00% | – |
Q1 2020 | $42,000 | -58.8% | 9,600 | -36.0% | 0.00% | – |
Q4 2019 | $102,000 | -16.4% | 15,001 | -40.1% | 0.00% | – |
Q3 2019 | $122,000 | -62.9% | 25,047 | -44.2% | 0.00% | – |
Q2 2019 | $329,000 | -67.5% | 44,873 | -64.1% | 0.00% | -100.0% |
Q1 2019 | $1,012,000 | +729.5% | 124,851 | +702.6% | 0.00% | – |
Q4 2018 | $122,000 | -77.7% | 15,556 | -69.4% | 0.00% | – |
Q3 2018 | $547,000 | +2.8% | 50,899 | +11.3% | 0.00% | – |
Q2 2018 | $532,000 | +31.4% | 45,731 | +191.3% | 0.00% | – |
Q1 2018 | $405,000 | +20150.0% | 15,698 | +10365.3% | 0.00% | – |
Q4 2017 | $2,000 | +100.0% | 150 | -57.1% | 0.00% | – |
Q3 2017 | $1,000 | -93.8% | 350 | -90.3% | 0.00% | – |
Q2 2017 | $16,000 | – | 3,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |